Organization Profile

You just read:

Oncolytics Biotech® Inc. Meets Primary Endpoint for First Stage of U.S. Phase 2 Metastatic Melanoma Trial

News provided by

Oncolytics Biotech Inc.

May 22, 2013, 06:30 ET